Jacobs, L.; Wauters, N.; Lablad, Y.; Morelle, J.; Taghavi, M.
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies 2024, 13, 21.
https://doi.org/10.3390/antib13010021
AMA Style
Jacobs L, Wauters N, Lablad Y, Morelle J, Taghavi M.
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies. 2024; 13(1):21.
https://doi.org/10.3390/antib13010021
Chicago/Turabian Style
Jacobs, Lucas, Nader Wauters, Yahya Lablad, Johann Morelle, and Maxime Taghavi.
2024. "Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria" Antibodies 13, no. 1: 21.
https://doi.org/10.3390/antib13010021
APA Style
Jacobs, L., Wauters, N., Lablad, Y., Morelle, J., & Taghavi, M.
(2024). Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies, 13(1), 21.
https://doi.org/10.3390/antib13010021